Acute Retinal Necrosis: Diagnosis and Management

Acute retinal necrosis (ARN) represents a medical emergency in ophthalmology, characterized by rapid destruction of the retinal tissue due to viral infection, primarily from the herpesvirus family. Prompt recognition and intervention are crucial to mitigate severe visual impairment.

Understanding the Pathophysiology of ARN

ARN arises from reactivation of latent herpes viruses, including varicella-zoster virus (VZV) and herpes simplex virus (HSV), which target the retinal layers, leading to inflammation, necrosis, and vascular occlusion. This process triggers a cascade of retinal cell death, often starting in the peripheral retina and progressing centrally if untreated. The condition predominantly affects otherwise healthy adults, though immunocompromised individuals are also at risk.

The inflammatory response exacerbates tissue damage through occlusive arteritis, resulting in ischemia and potential retinal detachment. Without therapy, the active phase persists for 6-12 weeks, underscoring the need for aggressive antiviral measures to halt viral replication.

Clinical Presentation and Early Warning Signs

Patients typically present with unilateral acute vision loss, floaters, or photophobia. Key ocular findings include patchy peripheral retinal whitening with scalloped borders, prominent vitritis, and sectoral retinal vasculitis. Anterior uveitis and elevated intraocular pressure may accompany these retinal changes.

• Sudden onset of blurred vision or scotomas in one eye.
• Intense eye pain and redness due to secondary inflammation.
• Fundoscopic evidence of yellow-white retinal patches progressing to confluence.

Bilateral involvement occurs in up to 70% of cases if the fellow eye is not protected systemically, highlighting the urgency of treatment.

Diagnostic Approaches: From Clinical Suspicion to Confirmation

Diagnosis begins with a thorough clinical examination, supported by multimodal imaging. Wide-field fundus photography documents peripheral involvement, while optical coherence tomography (OCT) reveals cystoid macular edema or epiretinal membranes. Fluorescein angiography demonstrates occlusive vasculopathy.

Polymerase chain reaction (PCR) testing of aqueous or vitreous humor is the gold standard, offering 95-97% sensitivity and specificity for identifying HSV, VZV, or cytomegalovirus (CMV). Treatment initiation should not await results due to rapid progression risks.

Serum antibody titers provide limited value, and immunocompromise screening (e.g., HIV) is essential.

Core Treatment Strategies: Antiviral Therapy

Systemic antivirals form the cornerstone, with intravenous (IV) acyclovir (13 mg/kg every 8 hours for 7-10 days) followed by oral agents like valacyclovir (1-2 g every 8 hours) or famciclovir (500 mg every 8 hours) for 3-6 months. Oral valacyclovir achieves acyclovir-equivalent plasma levels, enabling outpatient management.

For severe cases threatening the macula or optic nerve, adjunctive intravitreal injections of foscarnet (1.2-2.4 mg/0.1 mL) or ganciclovir (200-2000 μg/0.1 mL) enhance local concentrations, supported by level II/III evidence of superior efficacy over systemic therapy alone.

• Induction Phase: IV acyclovir or high-dose oral valacyclovir/famciclovir.
• Maintenance: Oral antivirals for 3-12 weeks, monitoring renal function.
• Adjunct Intravitreal: Foscarnet for posterior involvement or progression.

Anti-Inflammatory and Supportive Interventions

Corticosteroids (e.g., oral prednisone 0.5-2 mg/kg/day) are introduced 24-48 hours after antivirals or upon retinitis regression to curb inflammation, never in isolation during active necrosis. Topical steroids and cycloplegics manage anterior uveitis.

Aspirin may reduce thrombotic complications from vasculopathy, though evidence is anecdotal. Antithrombotics are physician-discretionary.

Surgical and Preventive Measures Against Complications

Retinal detachment (RD) risk reaches 40-75%, necessitating vigilant monitoring. Prophylactic laser barricade photocoagulation around necrotic zones aims to wall off progression, though efficacy remains unproven in randomized trials. Early pars plana vitrectomy (PPV) with silicone oil tamponade is considered for severe rhegmatogenous RD.

Long-term oral antivirals post-acutely prevent contralateral involvement or recurrence.

Prognostic Factors and Visual Outcomes

Poor prognosticators include older age, VZV etiology, macular/optic nerve involvement, and delayed therapy. Visual acuity improves in many with prompt treatment, but rhegmatogenous RD often leads to profound loss. Bilateral disease worsens prognosis.

Special Considerations in Immunocompromised Patients

In HIV or transplant patients, CMV may predominate, requiring valganciclovir (900 mg BID induction). Heightened vigilance for atypical presentations is needed.

Patient Education and Follow-Up Protocols

Educate on symptoms of fellow-eye involvement for immediate reporting. Regular wide-field imaging and OCT track progression. Lifelong antiviral prophylaxis may be warranted in high-risk cases.

Frequently Asked Questions (FAQs)

What causes acute retinal necrosis?

Primarily herpes viruses like VZV and HSV reactivating in the retina.

How quickly should treatment start?

Immediately upon suspicion; do not delay for PCR results.

Can ARN affect both eyes?

Yes, up to 70% risk without systemic therapy.

Is laser treatment always needed?

Not routinely; used prophylactically for RD prevention with uncertain efficacy.

What is the typical recovery time?

Active phase shortens to 4-6 weeks with antivirals.

Similar Articles

Alarming Rise in Self-Harm in Young People

Alarming Rise in Self-Harm in Young People

Skin Signs Of Non-Accidental Injury: Expert Guide For Clinicians

Lichen Simplex Of The Scrotum: Diagnosis And Treatment

Labial Adhesion In Prepubertal Girls: What Parents Need To Know

Thrush In Men: 5 Signs, Causes, And Treatment Options

Author

medha deb

 

Medha Deb is an editor with a master's degree in Applied Linguistics from the University of Hyderabad. She believes that her qualification has helped her develop a deep understanding of language and its application in various contexts.

Read full bio of medha deb